Answers are grounded in this paper and cite their sources.
Background: Gouty arthritis is a chronic inflammatory musculoskeletal disorder characterized by recurrent joint pain, inflammation, stiffness, and functional limitations, which can substantially affect patients’ physical, psychological, and social well-being. Conventional management primarily relies on pharmacological therapy; however, a comprehensive approach incorporating non-pharmacological strategies may provide better pain control and improve overall quality of life. The integration of optimized pharmacological therapy with physical therapy, lifestyle modification, dietary counselling, and mind-body interventions may offer a more effective approach to the long-term management of chronic gouty arthritis. Objectives: The study aims to evaluate the effectiveness of combined pharmacological and non-pharmacological interventions in reducing chronic pain among patients with gouty arthritis and to compare their outcomes with conventional treatment and improvements in quality of life. Methods: A prospective, randomized, controlled interventional study was conducted over a period of six months among 100 patients aged 30–80 years diagnosed with gouty arthritis and experiencing chronic pain. The intervention group received optimized pharmacological therapy along with structured physical therapy, lifestyle modification, dietary counselling, and mind-body interventions such as yoga and relaxation techniques, while the control group received conventional pharmacological treatment and routine physiotherapy. Pain intensity and quality of life were assessed at baseline and after six months using VAS and SF-36, respectively. Results: At baseline, the mean VAS pain scores were comparable between the intervention and control groups (7.2 ± 1.1 and 7.0 ± 1.3, respectively). After six months, the intervention group demonstrated a marked reduction in pain score from 7.2 ± 1.1 to 2.8 ± 1.0, representing a 61% reduction (p < 0.001), whereas the control group showed a reduction from 7.0 ± 1.3 to 4.9 ± 1.2, representing a 30% reduction (p < 0.05). The between-group difference was statistically highly significant (p < 0.001). Quality of life also improved substantially in the intervention group, with SF-36 scores increasing from 42.5 ± 6.3 to 72.8 ± 5.9, representing a 71% improvement (p <0.001). In comparison, the control group improved from 43.1 ± 5.8 to 58.6 ± 6.4, representing a 36% improvement (p < 0.05). The difference in quality-of-life improvement between the groups was highly significant (p < 0.001). Conclusion: This study demonstrates that combined pharmacological and nonpharmacological interventions are significantly more effective than conventional treatment in reducing chronic pain and improving quality of life among patients with gouty arthritis.
No takes yet. Share an insight, caveat, or question.
M et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: